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Macroautophagy is a cellular process involved in maintaining cellular 
homeostasis. It plays a role in many viral infections, but the exact role it takes is 
highly viral and cellular specific. The role of macroautophagy in filoviridae infection 
is poorly understood. Ebolavirus is a member of the filoviridae family, along with 
Marburg virus. Previous scientific literature has shown that large Marburg 
nucleoprotein inclusions can induce the formation of LC3 puncta, which is 
indicative of the activation of autophagy, and that the autophagy protein LC3 is 
required for Ebolavirus entry. This project aimed to understand which Ebolavirus 
proteins could activate autophagy, and what effect they have on the overall 
autophagy pathway. Initially, bioinformatics was used to predict which proteins may 
be able to activate autophagy by determining potentially functional LIR domains 
present within Ebolavirus proteins. These results were then tested experimentally. 
These experiments identified three Ebolavirus proteins that could potentially 
activate autophagy, zNP, zVP35 and zVP40. The effect of these proteins on the 
overall autophagy pathway was then investigated, looking at the maturation stages 
of the autophagy pathway. The results from these experiments suggested that the 
autophagosomes undergo fusion with lysosomes, but autophagic flux is inhibited. A 
trVLP system was used to look at the role of autophagy on the replication and 
budding of Ebolavirus. Results show that autophagy may play a role in aiding viral 
replication, but hindering the budding of virus like particles. Overall, this study 
showed that EBOV proteins are able to interact with the autophagy pathway, and 
the autophagy pathway may play a vital role in the replication process of 
Ebolavirus. 
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6FKHPDWLFGLDJUDPRIWKH(ERODYLUXVJHQRPHIURP¶WR¶HQGVKRZLQJWKH
main Ebolavirus proteins, with a schematic diagram of an Ebolavirus 
filamentous particle, showing GP on the surface [Mahanty,S., 2004] 
 





The first cases of haemorrhagic fever attributed to Ebolavirus were recorded 
in 1976. Since then Ebolavirus has been classified as belonging to the Filoviridae 
family, along with Marburg virus. Filoviruses are enveloped, non-segmented, 
negative sense RNA viruses with characteristic filamentous particles [Sanchez, A., 
1993]. Within Ebolavirus viral particles, the single stranded negative sense RNA 
genome is of 19kb length [Mahanty, S., 2004]. The genome contains seven genes, 
DUUDQJHGLQWKHIROORZLQJIDVKLRQ¶-NP-VP35-VP40-GP-VP30-VP24-L-5¶ as can 
be seen in Figure 1. Transcription of the genome begins aWWKH¶Hnd [Sanchez, A., 
1993]. Ebolavirus genes all encode single proteins, apart from GP, which encodes 
three separate proteins; glycoprotein (GP), soluble GP (sGP) and small soluble GP 
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All the Ebolavirus proteins play a part in the formation of new viral particles. 
GP is the only transmembrane surface protein, and forms trimeric spikes on 
filamentous particles, and is required for viral entry. The nucleoprotein (NP), VP30, 
VP35 and L all form part of the replication complex, with NP, VP30 and VP24 
forming nucleocapsids around new genomes. VP40 is a matrix protein that is 
required for virion structural integrity as well as viral egress. Ebolavirus proteins 
also interact with the host immune response, with VP35 and VP24 both interacting 
with the interferon response of host cells [Mahanty,S., 2004].  
1.1.1 Viral Spread 
Ebolavirus outbreaks are mostly recorded in humans and great apes, with 
high infection rates in both species. These species are thought to act as accidental 
hosts for the virus, due to the high mortality rates of infection within the species 
[Pratt, W.D., 2010]. The reservoir species for Ebolavirus has not yet been identified, 
although it could be maintained in small mammals such as rodents or bats. Recent 
findings suggest African fruit bats may serve as a reservoir species after detection 
of viral nucleotide sequence was identified in three fruit bat species [Leroy, E.M., 
2005]. However, the virus itself could not be isolated [Leroy, E.M., 2005].  
Little is known about the nature of transmission of Ebolavirus from bats or 
other reservoir species to humans [Pratt, W.D., 2010]. However, the nature of 
transmission of Ebolavirus between humans is well understood. Ebolavirus can be 
easily transmitted via many bodily fluids such as saliva and blood during the acute 
period of infection [Bausch, D.G., 2007]. However, if correct infection controls are in 
place, the transmission of Ebolavirus via fomites is very rare [Bausch, D.G., 2007].  
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A diagram to show the cells that Ebolavirus infects and the effect on the innate and 
adaptive immune system that infection has [Bray,M., 2005]. 
 
Figure 2: A schematic overview of Ebolavirus infection of human cells 
1.1.2 Symptoms of Ebolavirus Infection  
Initial symptoms of Ebolavirus infection often appear flu like, with symptoms 
including fever, chills, and malaise [Feldmann,H., 2011]. As the infection persists, multi 
system involvement appears, with gastrointestinal, respiratory and systemic 
symptoms appearing such as vomiting, abdominal pain, cough and prostration 
[Feldmann,H., 2011]. Haemorrhagic manifestations arise during the peak of the illness 
and include petechiae and ecchymoses. Patients with fatal disease develop clinical 
signs early during infection and die typically due to multiorgan failure [Feldmann,H., 
2011]. 
1.1.3 Clinical Manifestation 
 The initial target cells of Ebolavirus are dendritic cells and macrophages, as 
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These cells aid in the dissemination of the virus as they carry the virus to regional 
lymph nodes where the virus can replicate. Free and monocyte associated virions 
can travel through lymphatic channels and the bloodstream to many different 
tissues such as the spleen and liver, as well as infecting other cell types such as 
parenchymal cells, endothelial cells, epithelial cells and hepatocytes. This ability to 
spread throughout the body and infect many different tissue and cell types leads to 
multi organ infection [Feldmann,H., 2011].  
1.1.4 Immune Response 
 During Ebolavirus infection, a robust immune response is produced with the 
expression of many strong inflammatory mediators such as interleukins 2, 6, 8, and 
10, 71)ĮDQGUHDFWLYHR[\JHQDQGQLWURJHQVSHFLHV [Feldmann,H., 2011]. Expression 
of these mediators results in an immune imbalance during infection which 
contributes to the progression of the disease.  
 Two Ebolavirus proteins can interfere with the interferon response during 
infection. VP35 acts as a type I interferon antagonist by possibly preventing 
transcription of interferon ȕ as well as blocking activation of interferon regulatory 
factor 3 [Feldmann,H., 2011], while VP24 interferes with the type I interferon response 
by interacting with STAT1. 
 Reactive oxygen and nitrogen species play an important role during 
Ebolavirus infection. Nitric oxide when produced abnormally can result in tissue 
damage and loss of vascular integrity. Nitric oxide can also act as a mediator of 
hypotension, which is present during Ebolavirus infection [Feldmann,H., 2011]. EBOV 
induces abnormal levels of nitric oxide during infection which can lead to the 
apoptosis of lymphocytes. Lymphocyte apoptosis begins early in infection and can 
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also be caused by other mediators such as TNF-ĮUHVXOWLQJLQSURJUHVVLYH
lymphopenia throughout the course of infection [Bray,M., 2005]. During infection 
Ebolavirus can induce a robust immune response, which many of the symptoms of 
Ebolavirus can be attributed to. 
 
1.2 Ebolavirus Species  
 
 Within the Ebolavirus genus, there are five different species; Zaire 
ebolavirus (EBOV), Reston ebolavirus (RESTV), Sudan ebolavirus, Tai Forest 
ebolavirus and Bundibugyo ebolavirus [Kuhn, J.H., 2010]. The first outbreak in 1976 
was caused by the EBOV species and had a case fatality rate of 88%. Since then, 
there have been ten more outbreaks of Ebolaviruses which have been attributed to 
the EBOV species. EBOV has caused the most recorded outbreaks in humans, 
and has the highest mortality rate, with an average of 90% [Lefebvre, A., 2014].  
Another species of Ebolavirus, RESTV, was first identified in 1989 in 
Reston, USA in cynomolgus monkeys which had been imported from the 
Philippines [Miranda, M.E., 1999]. The clinical symptoms of the monkeys infected with 
RESTV were diarrhoea, respiratory illness and haemorrhage, and the source 
facility saw a case fatality rate of 82% in the monkeys [Miranda, M.E.G., 2011].There 
have been two more RESTV outbreaks in nonhuman primates ; in 1992 in Sienna, 
Italy and in 1996 in the USA [Miranda, M.E.G., 2011], with all outbreaks being 
attributed to monkeys imported from the Philippines. During these three outbreaks, 
458 people, who had some form of contact with the infected monkeys, were tested. 
Five samples came back seropositive for IgG antibodies to RESTV, showing a 
possibility for transmission between humans and monkeys [Miranda, M.E.G., 2011]. In 
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2008, RESTV was found in domestic pigs in the Philippines [Barrette, R.W., 2009]. 
There were 6 cases of humans being seropositive for IgG to RESTV [Barrette, R.W., 
2009], showing that the virus can transmit from swine to human. However, in all 
cases of RESTV transmission to humans, there was no evidence of disease within 
humans, making RESTV the only Ebolavirus species to be non-pathogenic to 
humans [Miranda, M.E.G., 2011] [Barrette, R.W., 2009].  
1.2.1 Pathogenicity of Different Species 
The reason behind the difference in pathogenicity between RESTV and the 
other species of Ebolavirus is still unknown. All Ebolaviruses produce the same 9 
proteins, but these proteins have been shown to contain amino acid changes which 
could account for the difference in pathogenicity. 189 Specificity Determining 
Positions, amino acids that are conserved between sub families, but differ between 
species, were determined between RESTV and pathogenic Ebolavirus [Pappaardo, 
M., 2016].  
These amino acid changes could account for the different interactions that 
occur with cellular pathways seen between EBOV and RESTV. EBOV VP35 and 
VP24 counteract the IFN response within cells leading to upregulation of IFN 
genes, while during RESTV infection there is a minimal change in expression of 
IFN genes [Olejnik,J., 2017]. Another pathway targeted during EBOV infection is the 
expression of cytokines and chemokines via the upregulation of genes involved in 
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1.3 Viral Replication 
 
Another reason for the reduction in pathogenicity could be due to the process 
of viral replication. The genome cannot be transcribed by host cell enzymes, 
requiring all components for viral replication to be carried with the virion, or to be 
produced during viral infection, [Mahanty, S., 2004], with an overview of this process 
being seen in Figure 3. 
Replication for Ebolavirus begins with entry of the virus into host cells. 
Ebolavirus is taken into host cells via the interaction of N- and O- linked glycans on 
GP with C-type lectins on the cell surface, as well as Phosphatidylserine (PtdSer) 
receptors on the cell surface interacting with PtdSer present in the viral envelope 
[Rhein, B.A., 2015]. C-type lectins are found on many different cell types such as 
macrophages and dendritic cells. This triggers a process known as 
Figure 3: A schematic overview of the viral replication cycle of Ebolavirus. 
Entry occurs via macropinocytosis, then the virion is released into the cell 
before viral replication occurs, involving inclusion bodies formed of NP,VP30, 
VP35 and L.GP and VP40 are involved in virion release [Messaoudi,I., 2015] 
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macropinocytosis, where the plasma membrane ruffles, allowing the virus to enter 
the cell. The virus enters the cell and is encapsulated in a macropinosome. The 
macropinosome then fuses with a Rab7 positive endosome, which causes the viral 
envelope to fuse with the cellular endosomal membrane, in a low pH, capthesin 
dependent manner [Nanbo, A., 2010]. Once fusion has occurred, the viral core is 
released into the cytoplasm. 
Once released into the cytoplasm, the replication cycle of Ebolavirus can 
begin. The replication complex is made up of VP30, NP, VP35 and L. This complex 
generates mRNA transcripts and copies the genome to produce full length positive 
sense RNA antigenomes, which act as templates for genome synthesis [Mahanty, 
2004]. NP, L, VP35 and VP24 form ribonucleoprotein complexes which can be 
found within nucleocapsids [Hoenen, T., 2012]. Nucleocapsids are rod-like 
filamentous particles which have a diameter of 50nm, and a 1000nm length. These 
nucleocapsids accumulate in viral inclusions bodies, which also contain NP, VP30, 
VP35 and L [Hoenen, T.,2012]. Inclusion bodies are located in the perinuclear region 
of the cell [Schudt, G., 2015], and these act as the site of viral replication.  
After the viral components have been replicated, the nucleocapsids are 
transported to the plasma membrane via actin polymerisation [Schudt, G., 2015], 
which requires VP40 [Noda, T., 2006]. VP40 is essential for viral release from the cell, 
as during the late stages of viral egress, VP40 recruits host proteins via its L 
budding domains which are essential for cell release [Han, Z., 2017]. Filamentous 
particles, containing nucleocapsids, are produced at the cell membrane [Noda, T., 
2006].  Filamentous particles can vary greatly in length but have a uniform diameter 
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of 80nm [Sanchez, A., 1993]. Virions bud from the cell as filamentous virions in a 
vertical manner [Noda, T., 2006].  
RESTV and EBOV both follow this viral replication route. However, there 
has been some evidence that viral replication occurs less efficiently in RESTV 
compared to EBOV, but the cause of this difference is still yet to be determined 
[Boehmann, Y., 2005].  
1.4 Cell Death Pathways  
 
As previously mentioned, during EBOV infection, lymphocytes undergo 
apoptosis [Bray,M., 2005]. Apoptosis is one of the cell death pathways that can be 
activated during viral infection, along with necrosis, and autophagy. Cell death 
pathways are activated during viral infection as a defence mechanism by the cells 
to prevent viral replication and spread. However, sometimes these pathways can 
aid the virus, as seen with lymphocyte apoptosis in EBOV infection. Lymphocyte 
apoptosis in EBOV infection suppresses the adaptive immune response produced 
by the host, allowing EBOV to replicate and disseminate throughout the body, 
leading to a fatal outcome for the host [Wauquier,N., 2010]. The role of other cell death 
pathways, such as autophagy, during EBOV infection are more poorly understood.  
1.5 Basic Autophagy 
Autophagy is a cellular process involved in maintaining cellular homeostasis, 
GXULQJZKLFKFHOOXODUFRQWHQWLVGHJUDGHGYLDDµVHOI-GLJHVWLRQ¶SURFHVV[Wong,A.S.L., 
2011]. There are three different forms of autophagy, which are defined by the way 
the cellular content is directed for degradation; chaperone-mediated autophagy, 
microautophagy and macroautophagy [Chiramel,A.I., 2013]. Macroautophagy, referred 
to as autophagy for the duration of this report, involves the formation of a 
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Following initiation, a phagophore is created. This then expands to form an 
autophagosome. The autophagosome can then either fuse with a lysosome or 
endosome, resulting in degradation of the cellular contents of the 
autophagosome [Chiramel,A.,I., (2013)].  
 
Figure 4: A schematic diagram to show the basic pathway of autophagy. 
phagophore, that evolves into a double membraned vesicle called an 
autophagosome [Chiramel,A.,I., 2013]. The autophagosomes surrounds the cellular 
contents intended for degradation [Hosokawa,N., 2009]. ]. Once formed, the 
autophagosome can either fuse with a lysosome to form an autolysosome 
[Hosokawa, N.,2009] or fuse with an endosome to form an amphisome [Chiramel, A.I., 
2013]. After fusion, degradation of the cellular contents of the autophagosome 
occurs. This pathway can be seen in Figure 4.  
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Autophagy can be induced via starvation to provide nutrients for the cell, 
during which non-specific methods are used to take up bulk cytoplasm resulting in 
the degradation of cytoplasmic content [Jager, S.,2004]. However, autophagy can 
also be activated and can selectively take up proteins, organelles, and intracellular 
pathogens [Wong, A.S.L., 2011], such as via the LC3 interacting protein p62. p62 
binds poly- and mono-ubiquitin proteins via its ubiquitin associated domain [He, C., 
2009], but can also bind LC3 via its LC3 interacting region (LIR) [Ichimura, Y., 2010]. 
This allows p62 to link its ubiquitinated cargos to autophagy machinery for 
autophagic degradation [He, C., 2009].  
1.6 Autophagy Pathway 
The initiation of autophagy requires the ULK complex [Wong,A.S.L., 2011], which 
consists of Atg13, ULK1 and FIP200 [Hosokawa,N.,2009].This complex is highly 
regulated via mTORC1, which can directly bind to the complex during high nutrient 
levels and prevent initiation of autophagy [Hosokawa,N., 2009]. Once initiated, the 
autophagy pathway begins with the formation of a flattened membrane sac called 
an isolation membrane or phagophore [Hosokawa,N.,2009]. The isolation membrane 
then undergoes elongation and nucleation to form vesicular structures; 
autophagosomes. Nucleation requires the formation of the PI3K/Beclin-1 complex, 
which is stimulated via the binding of UVRAG [Wong,A.S.L., 2011]. Following 
nucleation, elongation and expansion of the isolation membrane occurs via the 
binding of Atg proteins [Wong,A.S.L., 2011]. Atg5 forms a conjugate with Atg12 via an 
ubiquitination reaction involving Atg7 and Atg10 [Fujita,N., 2008]. This conjugate is 
essential for the elongation of the isolation membranes.  
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LC3-I is normally evenly distributed throughout the cytosol but becomes 
lipidated during autophagy to LC3-II, and localises to the inner and outer 
membranes of autophagosomes [Chiramel,A.I., 2013]. LC3-I forms an intermediate 
with Atg3 which is then activated via Atg7. This intermediate is then recruited to the 
isolation membrane via an interaction between Atg3 and Atg12. Once the Atg-LC3 
intermediate is in the proximity of the isolation membrane, LC3 can undergo 
ubiquitination reactions with PE, which leads to the lipidation of LC3-I to LC3-II 
[Fujita,N., 2008].  
Following elongation and closure of the isolation membrane to form the 
autophagosome, the autophagosomes fuse with early or late endosomes as well 
as lysosomes during autophagosomal maturation. Rab7 is a GTP binding protein 
required for the fusion of autophagosomes with endosomes and then lysosomes 





regarding the 22-residue peptide present in p62 that recognises LC3 [Kalvari, I., 
2014]. This was shortened to a stretch of 11 conserved acidic and hydrophobic 
residues that act as the interacting region for mouse p62-LC3. When structural 
data became available for the interaction between human p62-LC3 the interacting 
region was pinpointed to a tetrapeptide sequence of WxxL, with x standing for any 
residue. The tryptophan and leucine residues interact with hydrophobic pockets of 
LC3 [Kalvari, I., 2014]. A sequence was determined by Alemu and colleagues, using 
26 experimentally determined LC3 interacting regions. The typical sequence 
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pattern, [DE][DEST][WFY][DELIV]X[ILIV], carries through the WxxL motif [Alemu, 
E.A.,2012]. The newest consensus sequence is [ADEFGLPRSK] 
[DEGMSTV][WFY][DEILQTV] [ADEFHIKLMPSTV][ILV] [Jacomin, A-C., 2017].  LIRs 
allow proteins to interact with LC3, and this allows proteins either to be taken into 
autophagosomes to be degraded, or to affect autophagy in some way. Kalvari, and 
colleagues developed a computational approach to identifying these potential LIR 
domains using the consensus sequence. We previously determined the potential 
LIR domains of Ebolavirus, using the iLIR website (https://ilir.warwick.ac.uk/), with 
meaningful results being stated as results with PSSM scores of greater than 10. 
The PSSM score is an L x 20 scoring matrix with each element representing a log-
odds score for the presence of a residue in the respective position [Kalvari, I., 2014] 
Recently, Jacomin, and colleagues adapted the LIR website, to be specific for 
viruses, although there is currently only one LIR dependent interaction that has 
been reported, that of the M2 protein of the Influenza A virus [Jacomin,A-C., 
2017][Beale,R.,2014]. 
1.8 Role in Viral Infection 
 
Autophagy can be induced during a viral infection, but the autophagy 
response to a viral infection is highly viral and cellular specific. Autophagy can act 
as an anti-viral defence mechanism, with viral components being taken into 
autophagosomes and then degraded. Autophagy can also aid in the activation of 
the innate immune system by exposing pathogen-associated molecular patterns to 
innate immune sensors via viral components being taken up into autophagosomes, 
and these fusing with endosomes [Sparrer, K.M.J., 2018]. HIV-1 and HSV-1 are 
examples of viruses that are sensitive to viral clearance by autophagy [Sparrer, 
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MEF cells were transfected with Marburg NP and LC3. The presence of LC3 
puncta colocalising with NP was observed with large NP puncta [Dolnik,O., 2015]. 
Figure 5: Large NP inclusions co-localised with LC3 during Marburg virus 
infection in huh-7 cells. 
K.M.J., 2018]. On the other hand, viruses like Zika virus and Influenza virus can 
subvert autophagy, using it to promote viral replication [Sparrer, K.M.J., 2018].  
1.8.1 Role in Ebola Infection 
The role of autophagy during filoviridae viral infection is poorly understood. 
Marburg virus and Ebolavirus both produce nucleocapsids utilizing the same viral 
proteins, and viral RNA synthesis occurs in inclusion bodies for both viruses [Dolnik, 
O.,2015]. Dolnik et al (2015) showed that during Marburg virus infection, LAMP1 can 
be detected in VP40 clusters and in NP inclusions containing VP40, suggesting an 
interaction between LAMP1 and VP40 and its recruitment into inclusion bodies 
[Dolnik,O., 2015]. LC3 positive puncta were also detected in larger NP inclusions 
formed during Marburg virus infection, as can be seen in Figure 5 [Dolnik, O.,2015]. 
These results suggest a regulation of autophagy during Marburg virus infection, 
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FAM134 is part of the reticulon protein family and is an ER- resident 
receptor that can bind to autophagy modifiers LC3 and GABARAP [Khaminets, A., 
2015]. Via its ability to bind to autophagy modifiers, FAM134 can control 
endoplasmic reticulum turnover via selective autophagy [Khaminets, A., 2015]. In a 
2016 paper written by Chiramel, it was found that a specific FAM134, FAM134B, 
inhibits replication of Ebolavirus strains Makona and Mayinga, strains which belong 
to the EBOV species. When FAM134B is missing from cells, there are increased 
levels of viral replication, as well as increased expression of multiple viral proteins, 
increased inclusion body formation and greater production of infectious virus 
[Chiramel, A.I., 2016]. This shows that the turnover of the ER by autophagy is an 
important limiting factor to Ebolavirus replication. However, this paper does not 
show the effect of macroautophagy on Ebolavirus replication, instead showing that 
if there is a greater amount of ER present within the cell, then this allows for more 
general viral protein translation, not what effect the autophagy is having on the 
virus [Chiramel, A.I., 2016].  
A recent paper showed that the autophagy protein LC3 is required for EBOV 
internalisation into cells [Shtanke,O. 2018]. LC3B has been seen to associate with 
mature macropinosomes, suggesting that autophagy proteins may play a role in 
macropinocytosis; the entry method used by EBOV. The paper showed that LC3-I 
and LC3-II both associate with macropinosomes, but LC3-II is required for vesicle 
internalisation from the cell surface [Shtanke,O., 2018]. The paper also showed that 
EBOV associated with the macropinsomes that LC3 was interacting with. Overall, 
the paper shows that autophagy proteins, specifically LC3 -II, are required for 
EBOV internalisation into the cell after binding via GP [Shtanke,O., 2018]. 
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Our preliminary work showed that NP may be able to activate autophagy 
when transfected within Mouse Embryonic Fibroblasts (MEF) cells. The presence 
of LC3 puncta, which are indicative of autophagosomes, and increased levels of 
LC3-II, were seen and are shown in Figure 6. However, this work did not look at 
the full genome of EBOV to determine if NP is the only EBOV protein to activate 
autophagy, and whether this activation was having a pro-viral or anti-viral effect.  
 
1.9 Aims of the Project 
 
 The aims of this project were to determine which Ebolavirus proteins can 
activate autophagy, and the impact this has on viral replication. Firstly, the LIR 
domains present within the Ebolavirus proteins, that can activate autophagy, were 
determined. This was done by using the updated viral LIR web resource. Second, 
we looked for the presence of LC3 puncta within two cell lines, the previously used 
MEF cell line and a human cell line, HeLa, to determine the activation of autophagy 
by EBOV proteins. The next aim was to determine what effect the EBOV proteins 
were having on the maturation of the autophagy pathway. This was achieved by 
looking at the co-localisation of the EBOV protein with LAMP1 and LC3, and the 
Previously, LC3 puncta were seen in MEF 
cells transfected with GFP-LC3 and EBOV 
NP. LC3 puncta are seen as green, while 
nuclei were stained blue with DAPI. 
Figure 6: Induction of autophagy by zNP 
expression 
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degradation of p62, an autophagic flux marker.  The final aim of this project was to 
determine the effect autophagy has on the replication and budding of EBOV, by 
using a transcription and replication Virus Like Particle (trVLP) system in a wild 
type Hela cell line and +H/D¶V which are deficient in autophagy (HeLa-Hex). 
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2 Materials and Methods 
2.1 Mammalian Cell Lines 
 
Mouse Embryonic Fibroblasts, referred to as MEFs for this report, and HeLa cells 
were obtained from the Rossman laboratory. HeLa-Hex cells, containing CRISPR 
knock-outs of the eight Atg8 (LC3) family members were kindly provided by 
Michael Lazarou [Nguyen,T,N., 2016]. 
2.2 Tissue Culture  
CHOOVZHUHJURZQLQ'XOEHFFR¶V0RGLILHG(DJOH0HGLXP(DMEM) (PAN BioTech, 
UK) supplemented with 10% fetal bovine serum and 50ug/ml 
penicillin/streptomycin (Fisher Scientific). Cells were grown at 370c with 5% CO2. 
Cells were grown to confluency before being passaged, usually every 3-5 days.  
2.3 Plasmid Preparation  
 
Plasmids for each Ebolavirus protein were obtained from the US-NIAID BEI 
resource facility. Each PCAGGS plasmid confers resistance against ampicillin and 
expresses one single Ebolavirus protein. All EBOV plasmid proteins are tagged 
with a HA tag, apart from GP. EBOV trVLP plasmids (pCAGGS-NP, pCAGGS-
VP35, pCAGGS-VP30, pCAGGS-L, pCAGGS-T7, tetrascistronic minigenome, 
pCAGGS-Tim1) were kindly provided by Thomas Hoenen [Watt,A., 2014]. EGFP-LC3 
was a gift from Karla Kirkegaard (Addgene plasmid #11546). pLamp1-mCherry 
was a gift from Amy Palmer (Addgene plasmid #45147). 
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2.4 Plasmid Transfections 
 
Transfection of plasmids was carried out using PEI Transfection reagent 
(Polysciences). 1.5ug of plasmid was added to 100ul of Na-Cl. PEI transfection 
reagent was then added in a 4:1 PEI:DNA ratio. The complex was then vortexed 
for 5 seconds before incubating at room temperature for 10 minutes. The cell 
media was changed to an antibiotic free media, before 100ul of complex was 




Primary antibodies used were: anti- HA-probe (F-7) sc-7392, (Santa Cruz 
Biotechnology), anti-Ebolavirus GP, clone 15H10, NR-12184 (BEI Resources), 
anti-SQSTM1/ p62 ab56416 (Abcam),  
2.6 Fluorescence Microscopy Analysis ± Panel 
 
Cells were grown in 12-well plates on glass coverslips. At 80% confluency, the 
cells were transfected with viral protein expressing plasmid. After 24 hours, cells 
were washed with TBS twice and fixed using 10% formalin for 30 minutes. Cells 
were then permeabilized with 0.1% Triton X-100. After washing with TBS twice, 
blocking solution (1% BSA and 0.05% Tween20 in TBS) was added for 20 minutes. 
After washing with TBS, cells were incubated with primary antibody (anti-HA, or 
anti-GP). Primary antibody was prepared at the recommended dilutions with 
blocking solution. Primary antibody was incubated on the coverslip for one and a 
half hours at room temperature. Secondary antibody (Alexa Fluor 594 donkey anti-
mouse) was diluted at the recommended levels in blocking solution. This was 
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stored in darkness to prevent fluorescence bleaching. After aspirating off the 
primary antibody, the slides were washed three times in TBS before secondary 
antibody was added. Secondary antibody was incubated for one hour at room 
temperature. Secondary antibody was aspirated, and the cells were washed three 
times with TBS.  Cells were stained with Hoechst33342 for nuclear staining for 20 
minutes. Cells were washed three times with TBS before being blotted dry. Cells 
were mounted using Prolong Gold Antifade reagent (ThermoFisher Scientific). 
Slides were left to dry for ~16 hours before being visualised using a Zeiss confocal 
microscope. Appropriate lasers and filters were used to visualise the different 
stains using a 100x objective. Zen black was used to export the images.   
2.7 Fluorescence Microscopy Analysis ± Maturation  
 
Cells were grown and processed as above with the exception that cells were 
transfected at 70% confluency with viral protein expressing plasmids eGFP-LC3 
and Lamp1 mCherry expressing plasmids. After 48 hours, cells were processed, 
stained with anti-HA and Alexa Fluor 680 donkey anti-mouse secondary antibody 
and imaged as above.  
2.8 Western Blot Analysis 
 
Cells were plated in a 12-well plate. When they reached 70% confluency, they 
were transfected with viral protein expressing plasmid. After 42 hours, EBSS and 
chloroquine (50µM) were added as positive controls. After 48 hours, cells were 
lysed using NP-40 lysis buffer containing Complete Mini protease inhibitor. Lysates 
were then centrifuged at 13, 300 rpm for 10 minutes and the supernatants were 
collected. Samples were separated using a Bio-Rad Criterion TGX Stain-Free Any 
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kD precast gel which was run for 60 minutes at 120V. The gels were transferred to 
a Polyvinylidene difluoride membrane using the Bio-Rad Trans-Blot Turbo Transfer 
System. The membranes were blocked using 5% w/v milk in 0.1% Tween20/TBS 
and incubated overnight in primary antibodies diluted in TBS-T. Horseradish 
peroxidase-conjugated donkey anti-mouse secondary antibody was then applied 
for an hour, before applying enhanced chemiluminescence reagents 1 and 2 (Bio-
Rad) in a 1:1 ratio, to the blot. Visualisation was done using a SynGene G: Box 
using the GeneSys system for automatic imaging, and the processed using ImageJ 
for band intensity. 
2.9 trVLP system 
 
Producer cells were grown in a 6 well dish. At 50% confluency, the cells were 
transfected with 125ng pCAGGS-VP35, 75ng pCAGGS-VP30, 1000ng pCAGGS-L, 
250ng tetracistronic minigenome expression plasmid, 250ng pCAGGS-T7 and 
125ng pCAGGS-NP as previously described [Watt,A., 2014]. 72 hours later, the 
trVLP-containing supernatant of the p0 producer cells was clarified by 
centrifugation for 5 minutes at 800xg, room temperature. 1.5ml of the clarified 
supernatant was transferred onto p1 cells that had 24 hours previously been 
transfected with 125ng pCAGGS-NP, 125ng pCAGGS-VP35, 75ng pCAGGS-
VP30, 1000ng pCAGGS-L, and 250ng pCAGGS-Tim1. p0 cells were then lysed 
using NP-40 lysis buffer with Complete Mini Protease Inhibitor. 30 minutes later, 
cells were resuspended in the lysis buffer. Lysates were then clarified by 
centrifugation for 10 minutes at 13,000rpm. 40ul of lysate was then added to 40ul 
RenillaGlo substrate in white 96 well plates. After incubation for 10 minutes, Renilla 
luciferase reporter activity was measured using a CLARIOstar plate reader. 72 
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hours later, p1 cells were lysed using NP-40 lysis buffer with Complete Mini 
Protease Inhibitor. 30 minutes later, cells were resuspended in the lysis buffer. 
Clarified lysates luciferase reporter activity was then measured.  
 
2.10 Determination of LIR domains 
 
Using the iLIR viruses website (http://ilir.uk/virus/), the potential LIR domains in all 
Zaire (Mayinga strain 76) proteins and all Reston (Reston strain 89) proteins were 
determined using the Search tool available on the website. To determine which of 
these potential LIR domains are most likely to be functional, the PSSM score of 
each protein was identified. PSSM scores between 9 and 18 were validated for 
their accuracy, sensitivity, and specificity.  PSSM scores that lie between 13 and 
17 were concluded to be meaningful values from this due to the levels of specificity 
and sensitivity [Kalvari, I., 2014]. However, when experimentally determined LIR 
domains were tested, PSSM scores as low as 7 were shown in functional LIR 
domains. Due to these experimentally determined /,5¶V PSSM scores, and the 
specificity and sensitivity of the PSSM scores, a PSSM score of 11 was used to 
determine potential LIR domains present in Zaire and Reston Ebolaviruses. 
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3 Results 
3.1 Determination of Potential LIR domains 
 
 The aim of this experiment was to determine which EBOV proteins might 
interact with the autophagy pathway by looking for the presence of LIR domains 
within each EBOV protein sequence. To determine the domains most likely to 
encode functional LIR domains, the PSSM score is used as a measurement. 
Results show that zVP35 contains the most likely functional LIR domain (Table 1), 
with a total of 9 meaningful potential LIR domains across all the EBOV proteins 
















zVP35 322 327 RGWVCV 16 
zL 290 295 DGYKII 13 
zL 424 429 GSWYSV 13 
zL 714 719 KLWTSI 13 
zVP40 93 98 PIWLPL 13 
zL 492 497 TCWDAV 12 
zL 1116 1121 YSWAHI 12 
zNP 189 194 TAWQSV 12 
zVP40 245 250 QDFKIV 11 
Table 1: Meaningful potential LIR domains in EBOV proteins 
LIR domains that satisfy certain criteria were ordered per PSSM score.  
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The same criteria were applied to the potential LIR domains in RESTV. 
Overall, there are more meaningful potential LIR domains present in RESTV 
compared to EBOV (Table 2). Many of these LIR domains have higher PSSM 
scores compared to their EBOV counterparts, apart from rVP40 (Table 2). rVP35 
still contains the most likely functional LIR domain (Table 2).  




rVP35 311 316 RGWVCL 17 
rL 177 182 DEFIDI 14 
rNP 599 604 PDYTAV 14 
rGP 21 26 LVWVII 14 
rL 424 429 GTWYSV 13 
rL 714 719 KLWTSI 13 
rL 1116 1121 YTWSHI 13 
rVP40 93 98 PIWLPL 13 
rL 349 354 RDFHKI 12 
rL 492 497 TCWDAV 12 
rNP 189 194 TAWQSV 12 
rGP 3 8 SGYQLL 12 
rL 290 295 EGYKII 11 
rL 894 899 LDYGTI 11 
rNP 19 24 LDYHKI 11 
rNP 729 734 DKFLAI 11 
 
Table 2: Meaningful potential LIR domains in RESTV proteins 
LIR domains that satisfy certain criteria were ordered by PSSM score 
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To try and determine why the difference in LIR domains occurs between 
RESTV and (%296'3¶V were cross referenced against the meaningful potential 
LIR domains of RESTV6'3¶VFDQKDYHIRXUGLIIHUHQWHIIHFWVRQWKH/,5VRI
RESTV compared to EBOV /,5¶V; the LIR could disappear due to the SDP, a new 
LIR could appear due to the SDP, the PSSM score of the LIR could be affected 
due to the SDP, or there could be no effect on the LIR. There are five meaningful 








These results suggest that both EBOV and RESTV contain LIR domains, and 
specific proteins will be able to interact with the autophagy pathway, although 
RESTV is predicated to contain more, and stronger domains.  
 





rNP 599 604 PDYTAV 14 New 
rL 1116 1121 YTWSHI 13 PSSM increase  
rL 349 354 RDFHKI 12 New 
rGP 3 8 SGYQLL 12 New 
rL 894 899 LDYGTI 11 PSSM increase  
Table 3: Meaningful potential LIR domains in RESTV proteins that overlap 
with a SDP 
LIR domains that overlap with an SDP region in RESTV are listed, ordered by their 
PSSM scores. The SDP within the LIR sequence is highlighted in red.  
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3.2 Optimization of PEI Transfection 
 
Evaluation of the optimal amount of plasmid for transfection was tested using 
titrations of 0.5ug, 1.0ug, 1.5ug and 2.0ug zNP in HeLa cells grown on glass 
coverslips. 24 hours post transfection, cells were fixed and stained for HA, and 
imaged by epifluorescence microscopy (Figure 7). Optimal amount of plasmid was 











Figure 7:Optimization of PEI Transfection in HeLa cells 
HeLa cells were transfected with varying amounts of zNP, as indicated besides the 
images. All slides were fixed and stained for NP (green), with nuclei being stained with 
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3.3 Induction of Autophagy by specific EBOV proteins 
 
To get a comprehensive look at how EBOV may interact with autophagy, all 
EBOV proteins were tested for induction of autophagy. Firstly, MEF cells were 
transfected with individual EBOV protein expression plasmids, then 24 hours later, 
fixed, and imaged via fluorescence confocal microscopy (Figure 8). When there is 
little or no induction of autophagy in a cell, LC3 is seen evenly distributed 
throughout the cytosol, but during induction of autophagy, LC3 is redistributed to 
autophagosomes and this is seen as bright puncta. To get an idea of the basal 
level of autophagy in the cells, a negative control transfection of the empty vector 
plasmid pCAGGs was run. In the negative control, LC3 can be seen to be evenly 
distributed throughout the cell with only very small bright puncta formation, 
indicating the steady state levels of autophagy (Figure 8 and 9). zNP expression 
causes the greatest induction of autophagy of the EBOV proteins with numerous 
puncta formation, and puncta being distributed throughout the cytosol (Figure 8). 
zVP35 and zVP40 both also caused the formation of a few small puncta, which 
were close to the nucleus and distributed throughout the cytosol respectively 
(Figure 8). zVP30 also caused the formation of a few small puncta, which are 
located within the cytosol (Figure 8). This test was then re-run in human HeLa cells 
(Figure 9). Again, zNP, zVP35 and zVP40 all showed induction of autophagy with 
puncta being distributed evenly throughout the cytosol (Figure 9), but zVP30 
showed no induction of autophagy (Figure 9). 
Rebecca Steventon  
 





Figure 8: Specific EBOV proteins activate autophagy in MEF cells 
MEF cells were transfected with individual EBOV proteins, as indicated besides the 
images, and GFP-LC3. Activation of autophagy is seen by the formation of LC3 
puncta. LC3 puncta can be seen as bright green dots, or aggregations. All slides 
were fixed at 24hrs post transfection and analysed by confocal microscopy. Nuclei 
are stained blue by Hoechst33342. 
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Figure 9: Specific EBOV proteins activate autophagy in HeLa cells 
HeLa cells were transfected with individual EBOV proteins, as indicated besides the 
images, and GFP-LC3. Activation of autophagy is seen by the formation of LC3 puncta. 
LC3 puncta can be seen as bright green dots, or aggregations. All slides were fixed at 
24hrs post transfection and analysed by confocal microscopy. Nuclei are stained blue 
by Hoechst33342.  
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3.4 Co-localisation of EBOV proteins with LC3 puncta 
 
Whether the proteins are interacting with the autophagosomes or are just 
activating the autophagy pathway is an important distinction to determine. Co-
localisation of the EBOV proteins and LC3 puncta was used to determine this. The 
three EBOV protein expression plasmids previously seen to activate autophagy 
were transfected into HeLa cells along with eGFP-LC3. 24 hours later, the cells 
were then fixed, and stained for the HA expression tag, before being imaged by 
confocal microscopy. zNP and GFP-LC3 are seen to co-localise with the formation 
of large aggregates containing both zNP and LC3 (Figure 10). zVP35 also appears 
to co-localise with LC3, with some of the LC3 puncta also being positive for the 
presence of zVP35 (Figure 10). However, there are some LC3 puncta that do not 
co-localise with zVP35. Only a few LC3 puncta appear to co-localise with zVP40 
(Figure 10).  
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GFP-LC3 HA tag Merge 
HeLa cells transfected with GFP-LC3 and individual EBOV protein 
expression plasmids.24 hours after transfection, cells were stained for HA 
(red) and then viewed using fluorescence confocal microscopy. 
Figure 10: EBOV proteins co-localise with LC3 puncta 
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3.5 Lamp1 and LC3 co-localisation  
 
Co-localisation of Lamp1 with the LC3 puncta can be used as an indicator to 
assess autophagy maturation. EBOV protein expression plamids for zNP, zVP35 
and zVP40 previously seen to activate autophagy were transfected into HeLa cells 
along with eGFP-LC3 and Lamp1-mCherry. 48 hours later, the cells were then 
fixed, and stained for the HA expression tag before being imaged via fluorescence 
confocal microscopy. Transfection with PCAGGs was used to determine basal 
levels of LAMP-1 within the cell, and normal co-localisation of LAMP-1 with LC3. 
LAMP-1 is normally evenly distributed throughout the cell but will co-localise with 
LC3 in maturing autophagosomes (Figure 11). When transfected with zNP, large 
LC3 puncta formation occurs, and LAMP-1 is also seen to co-localise with the LC3 
puncta. zNP itself can also be seen to form puncta which co-localise with both LC3 
and LAMP-1 (Figure 11). The same can be seen with zVP35; LAMP-1 puncta 
formation occurs, and these puncta co-localise with LC3 puncta along with the 
zVP35 protein (Figure 11).  When transfected with zVP40, Lamp1 puncta can be 
seen to form alongside LC3 puncta, which co-localise with the Lamp1 puncta. 
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HeLa cells were co-transfected with eGFP-LC3, EBOV protein expression plasmids 
and mCherry-Lamp1. 48 hours post transfection, cells were fixed, and stained, 
before being mounted. EBOV proteins were stained pink via a HA expression tag 
and nuclei were stained blue with Hoechst33342. Images were viewed using 
fluorescence confocal microscopy. Lamp1 and LC3 puncta are seen to co-localise.  
Figure 11: EBOV proteins induce autophagosome maturation  
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3.6 EBOV proteins increase p62 levels  
Another way to determine whether maturation of the autophagy pathway is 
occurring is to look at the level of p62. p62 is taken into autophagosomes through 
selective binding to LC3 and is then degraded through autophagosomal 
maturation. Due to this, levels of p62 correlate inversely to autophagic maturation.   
HeLa cells were transfected with two positive controls; EBSS to induce autophagy 
via starvation, and chloroquine to inhibit autophagosomal maturation, as well as a 
negative control and the three EBOV protein expression plasmids seen to activate 
autophagy; zNP, zVP35 and zVP40. 48 hours later, cells were lysed and run on a 
Western Blot which was stained for p62 and imaged. Levels of p62 were quantified 
using the data analysis software ImageJ. When autophagy is induced via 
starvation, levels of p62 are decreased, while when autophagy maturation is 
inhibited, levels of p62 increase (Figure 12). The negative empty vector control of 
pCAGGs shows a p62 level in between the two positive controls, as would be 
expected (Figure 12). All EBOV proteins show increased levels of p62 compared to 
pCAGGS (Figure 12). zVP35 shows a p62 level very close to the level of the 
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To determine whether this increase in p62 was due to the EBOV proteins 
preventing the maturation of the autophagosomes, or whether they were causing 
an overexpression of p62, the levels of p62 in the presence or absence of 
chloroquine were compared. The levels of p62 increased when chloroquine was 
added to the negative control of PCAGGS, as would be expected (Figure 13).  
Levels of p62 for zNP, zVP35 and zVP40 transfected cells all stayed relatively 
similar in the absence and presence of chloroquine. 
 
HeLa cells were transfected with negative control, or EBOV protein expressing 
plasmids. 44 hours later, EBSS or Chloroquine controls were added. 4 hours later, 
cells were lysed and run on a Western Blot 
(A) Western Blot showing levels of p62 and actin in HeLa cells 24 hours post 
transfection. 
(B) Relative density of p62 levels from 3 Western Blots. Analysed via ImageJ, with 
standard deviations shown. 
Figure 12: Specific EBOV proteins increase the level of p62 in HeLa cells 
B. 
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HeLa cells were transfected with negative control, or EBOV protein expressing 
plasmids. 44 hours later, chloroquine was added to certain samples. 4 hours later, cells 
were lysed and run on a Western Blot 
(A) Western Blot showing levels of p62 in HeLa cells in the absence or presence of 
chloroquine. 
(B) Relative density of p62 levels in HeLa cells in the absence or presence of 
chloroquine. Analysed via ImageJ.  
 
Figure 13: Levels of p62 remain similar for EBOV proteins in the absence 
and presence of chloroquine 
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3.7 Decrease in viral replication of EBOV in HeLa-Hex cells compared 
to HeLa cells 
To determine whether autophagy is playing a role in the replication of EBOV, a 
trVLP system was used [Watt,A., 2014]. A trVLP system uses a minigenome 
construct that encodes a luciferase gene and 3 EBOV proteins. 
 
This minigenome construct was transfected into HeLa or autophagy-
incompetent HeLa-Hex cells along with the other 4 EBOV proteins, enabling the 
production of VLPs and the assessment of viral replication via luminescence. 72 
hours later, the cells were lysed, and the luciferase reporter activity was 
determined (Table 4). To determine the background luciferase reporter activity, a 
negative control of untransfected cell lysate was used. Results from the HeLa and 
A schematic diagram showing the trVLP system that involves the 
transfection of the minigenome and four other EBOV proteins into cells 
where replication, transcription, and budding can occur, and the passage 
of these VLPs onto new cells where entry can occur [Watt,A., 2014]. 
Figure 14: A schematic diagram showing the trVLP system 
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HeLa -Hex cells were then equalised according to this control (Figure 15). 
Luciferase reporter activity was higher in the cell lysate from HeLa cells, when 
compared to the luciferase reporter activity from the HeLa- Hex cell lysates, 
suggesting that autophagy enhances EBOV replication (Figure 15). A student t-test 
was run to determine the statistical difference between the luciferase reporter 
activity of the HeLa and HeLa-Hex cells. The p value was less than 0.001 with a 
confidence interval of 95%. This difference is considered to be extremely  







Cell Type Sample 1 Sample 2 Sample 3 Mean 
HeLa1 6435 5988 6045 6156 
HeLa2 6695 6548 6448 6564 
HeLa3 7078 6963 7592 7211 
Hex1 3366 3517 3658 3514 
Hex2 3288 3471 3210 3323 
Hex3 3819 3391 3776 3662 
Control  658 661 609 643 
HeLa and HeLa-Hex cells were transfected with a trVLP system containing a luciferase 
gene. 72 hours later, the cells were lysed. Luciferase reporter activity was measured, 
and the mean activity determined.  
Table 4: Luciferase Reporter Activity in HeLa, HeLa -Hex and Control in p0 
cells 
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HeLa and HeLa-Hex cells were transfected with an EBOV trVLP system containing a 
luciferase gene. 72 hours later, cells were lysed. Luciferase reporter activity of cell 
lysates were measured and equalised to the control. Standard deviation for each 
measurement is shown. 
Figure 15: Luciferase Reporter Activity in p0 HeLa and HeLa - Hex cells 
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3.8 Increase in budding of EBOV in HeLa-Hex cells compared to HeLa 
cells 
To determine whether autophagy is playing a role in the budding of EBOV, the 
trVLP system was used. The trVLP system was transfected into HeLa or HeLa-Hex 
p0 cells. 72 hours later the clarified supernatants were added to p1 HeLa cells. A 
further 72 hours later, the cells were lysed, and the p1 luciferase reporter activity 
was determined, providing an indication of differences in the amount of VLPs 
produced by the HeLa vs HeLa-Hex p0 cells (Table 5). To determine the 
background luciferase reporter activity, a negative control of untransfected cell 
lysate was used. Results from the HeLa and HeLa-Hex VLPs were then equalised 
according to this control (Figure 16).  Luciferase reporter activity is higher following 
infection with VLPs produced from HeLa p0 cells compared to HeLa-Hex p0 cells 
(Figure 16). 
Cell Type Sample 1 Sample 2 Sample 3 Mean 
HeLa1 2784 2603 2902 2763 
HeLa2 2128 2061 2256 2148 
HeLa3 2216 2096 2498 2270 
Hex1 1634 1641 1885 1720 
Hex2 1990 1844 1874 1903 
Hex3 1781 1727 1771 1760 





HeLa and HeLa-Hex p0 cells were transfected with a trVLP system containing a 
luciferase gene. 72 hours later, the supernatant was added to p1 HeLa cells. A further 
72 hours later the cells were lysed. Luciferase reporter activity was measured.  
 
Table 5: Luciferase Reporter Activity in control and p1 HeLa cells, following 
infection of trVLPs produced from HeLa, HeLa-Hex and Control in p0 cells 
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Luciferase reporter activity in p0 cells measures viral transcription and 
replication, whereas reporter activity in p1 cells measures VLP entry, viral 
transcription and replication as well as transcription, replication and budding from 
p0 cells. All p1 cells were HeLa cells and so should have equal entry, replication 
and transcription. To distinguish the impact autophagy has on budding as 
compared to transcription and replication, the p1 results were compared to the p0 
results as the p0 results depend on only replication and transcription. The 
luciferase reporter activity for all cell types dropped in p1 cells compared to p0 cells 
HeLa and HeLa-Hex p0 cells were transfected with an EBOV trVLP system containing 
a luciferase gene. 72 hours later, supernatant was added to HeLa p1 cells. Luciferase 
reporter activity of cell lysates of p1 cells were measured and equalised to the control. 
Standard deviation for each measurement is shown. 
Figure 16: Luciferase Reporter Activity in HeLa p1 cells following infection 
with supernatant from HeLa and HeLa-Hex p0 cells 
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(Figure 17). A student t-test was run to determine the statistical significance of the 
difference between the p0 and p1 results of HeLa cells and the difference between 
the p0 and p1 results of HeLa-Hex cells. The p value was 0.9875 with a confidence 
interval of 95%. These results are considered to be not statistically significant. The 
percentage decrease between p0 and p1 cells was also determined (Figure 18). 
HeLa cells have a greater decrease between p0 and p1 cells compared to HeLa-




The luciferase reporter activity of HeLa and HeLa-Hex p0 cells and the luciferase 
reporter activity of HeLa and HeLa-Hex supernatant infected HeLa p1 cells were 
compared. Standard deviation for each measurement is shown. 
Figure 17: Comparison of luciferase reporter activity in p0 and p1 cells 
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The percentage decrease between the luciferase reporter activity of HeLa and 
HeLa-Hex p0 cells and the luciferase reporter activity of HeLa and HeLa-Hex 
supernatant infected HeLa p1 cells was calculated.  
Figure 18: Percentage Decrease in Luciferase reporter activity between p0 
and p1 cells 
Rebecca Steventon  
 




This project aimed to determine if EBOV proteins are able to activate 
autophagy, what effect they have on the maturation of the autophagy pathway, and 
the overall effect the autophagy pathway has on the replication of EBOV. Through 
bioinformatical methods, it was determined that EBOV proteins NP, VP35, VP40 
and L may activate the autophagy pathway. This was then confirmed via 
experimental methods; by looking for the presence of LC3 puncta. These 
experiments showed experimentally that NP, VP35 and VP40 can induce 
autophagy.  Their effect on the maturation of the autophagy pathway was then 
determined. Lamp1 experiments showed co-localisation of Lamp1, LC3 and EBOV 
proteins, while p62 experiments showed increased p62 levels with EBOV proteins, 
suggesting complete maturation of the autophagy pathway does not occur when 
EBOV proteins are present. A trVLP system was then used to determine the 
overall effect of autophagy on EBOV replication and budding. EBOV replication 
was roughly halved when autophagy was inhibited, but budding seemed to 
increase when autophagy was inhibited, suggesting that autophagy may play a 
significant role in both viral replication and budding.  
4.2 Determination of potential LIR domains  
4.2.1 Determination of proteins that may be able to activate autophagy 
Many viruses interact with the host autophagy pathway during viral infection. 
There is currently no published scientific literature into the activation of autophagy 
via EBOV proteins, therefore determining if EBOV can activate and if so which 
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proteins may be able to activate autophagy was a main priority. Determination of 
potential LIR domains present within the amino acid sequence of the seven main 
EBOV proteins allowed determination of the proteins that may be able to activate 
autophagy (Table 1). All the potential LIR domains present within the seven main 
EBOV protein amino acid sequences where determined using a viral LIR database 
[Jacomin,A-C., 2017] (Supplementary 7.1).  
All the predicated LIR domains generated via the database are not likely to be 
functional. To determine which ones were most likely to be functional, the PSSM 
score generated via the database was used. The PSSM score is a position specific 
scoring matrix generated by the database and is based on a log-odds score of a 
residue being present at a specific position [Kalvari,I., 2014]. The higher the PSSM 
score, the more likely it is that the domain is functional. PSSM scores of previously 
experimentally determined LIR domains, and the specificity and sensitivity scores 
RIGLIIHUHQW3660¶VZHUHXVHGWRGHWHUPLQHWKHORZHU3660VFRUHOLPLWIRUWKLV
study. A PSSM score limit of 11 was set. 
 Four EBOV proteins contained LIR domains that satisfied the criteria set out; 
zVP35, zVP40, zL and zNP as seen in Table 1. This suggests that these four 
proteins may be able to activate autophagy. Only one experimentally determined 
viral LIR domain exists, an LIR domain in the tail end of the M2 protein of the 
Influenza A virus [Beale,R.,2014]. This domain allows the M2 protein to directly bind 
to LC3, and cause LC3 to translocate to the plasma membrane. When LC3 binding 
is inhibited via mutations, there is reduced virion stability and interference with 
filamentous budding [Beale,R.,2014].   The LIR domains identified within the EBOV 
proteins may also act in the same way, subverting the autophagy pathway to aid in 
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viral replication, or could interact with the autophagy pathway in an alternative 
way.h 
4.2.2 Difference in potential LIR domains between EBOV and RESTV 
RESTV is the only Ebolavirus species that is non-pathogenic to humans, but 
the reason for this difference is still to be determined. A reason for this difference 
could lay in different interactions with the autophagy pathway between RESTV and 
the other Ebolavirus species. The RESTV protein amino acid sequences of the 
seven main RESTV proteins were run through the LIR database [Jacomin,A-C., 2017] 
(Supplementary 7.2). The same criteria that was previously applied to the EBOV 
proteins was applied to the potential LIR domains present within the RESTV 
proteins. There were more potentially functional domains present within RESTV 
proteins compared to EBOV proteins as seen in Table 2. There were five RESTV 
proteins that contained potentially functional domains, with four of these being the 
same proteins seen in EBOV, with rGP being the only new protein to show 
potentially functional LIR domains. The increase in domains suggests that RESTV 
proteins may be able to activate the autophagy pathway better than EBOV 
proteins.  
4.2.3 CroVVRYHURI/,5GRPDLQVZLWK6'3¶V 
Specificity Determining Positions are amino acids that stay the same within 
sub-VSHFLHVEXWGLIIHUEHWZHHQVSHFLHV6'3¶VKDYHEHHQGHWHUPLQHGEHWZHHQ
RESTV and the pathogenic strains of Ebolavirus [Pappaardo,M., 2016]. These SDPs 
could account for the difference seen in the amount and likely functionality of the 
LIR domains between EBOV and RESTV. To test this hypothesis, the potentially 
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functional LIR domains present within RESTV were cross referenced with the 
known SDPs present within RESTV. Five of the potentially functional LIR domains 
present within RESTV crossed over with SDPs as seen in Table 3. This crossover 
resulted in the presence of three potentially functional LIR domains in RESTV 
proteins which DUHQ¶WSUesent in EBOV, while two potentially functional LIR domains 
had higher PSSM scores in RESTV compared to EBOV. The crossover of the 
SDPs with the LIRs appears to increase the presence of LIRs and the ability to 
bind to LC3, thus making it likely that they are increasing the interaction of the 
proteins with the host autophagy pathway. This could suggest that autophagy is 
acting in anti-viral way during Ebolavirus infection, and this is what leads to 
difference seen in pathogenicity between EBOV and RESTV. However, there is a 
lot of conservation of LIRs domains between EBOV and RESTV. This conservation 
of LIRs domains could suggest that autophagy is essential for efficient viral 
replication, and so cannot be mutated between species without losing viral 
replication. The difference seen in LIRs domains would then suggest that 
increasing autophagy could limit some part of the Ebolavirus life cycle, limiting viral 
replication in some way in RESTV compared to EBOV, leading to the difference in 
pathogenicity.  
4.3 Autophagy induction by specific EBOV proteins 
After determining which proteins may be able to activate autophagy via 
bioinformatics, an experimental method was used to test which ones could activate 
autophagy within the laboratory setting. This was done by looking for the presence 
of autophagosomes via immunofluorescence microscopy.  GFP-LC3 is a fusion 
protein where GFP is present at the amino terminus of LC3. During autophagy LC3 
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becomes conjugated with PE to form LC3-II, which associates with both the inner 
and outer membranes of autophagosomes [Mizushima,N., 2010]. Using the fusion 
protein GFP-LC3, the presence of LC3 can be viewed via immunofluorescence, 
with it being either diffuse throughout the cytoplasm, or as punctate structures that 
represent autophagosomes [Mizushima,N., 2010] .   
Previous work carried out in MEF cells had showed that zNP and zVP35 
were able to cause autophagy induction (Supplementary 7.3). These results were 
confirmed with zVP35 and zNP still showing autophagy induction as seen in Figure 
8.  Of the other EBOV proteins tested, zVP30 and zVP40 also showed autophagy 
induction as seen in Figure 8.  
Autophagy is highly cellular specific [Sharifi,M,N., 2015], and EBOV proteins 
have different interactions in mouse cell lines compared to human cell lines 
[Martinez,O., 2013]. Due to this, autophagy induction was also tested in the human 
cell line HeLa. zVP35, zVP40 and zNP again all showed autophagy induction, as 
seen in Figure 9. In comparison to the induction of autophagy in the MEF cell line, 
all three proteins were able to induce autophagy to a greater degree in the HeLa 
cell line, with more puncta being seen throughout the cells. Within the HeLa cell 
line, zNP can be seen to cause the formation of large aggregates which are 
indicative of significant activation of the autophagy pathway. However, zVP30 
showed no formation of LC3 puncta, suggesting that within a human cell line 
zVP30 is not able to activate autophagy. 
Previous work showed that Marburg NP, a protein very similar to EBOV NP, 
was able to cause the formation of LC3 positive punctate structures, when large 
Marburg NP inclusions were formed [Dolnik, O.,2015]. Marburg uses inclusion bodies 
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for RNA synthesis in the same way as EBOV. This paper suggested that Marburg 
may regulate the autophagy pathway during infection either usurping it for viral 
replication or acting as a target for the autophagosomal pathway [Dolnik,O., 2015]. 
These results suggest that these EBOV proteins could be activating autophagy via 
similar methods as Marburg as similar results have been seen, and the proteins 
themselves have similar structures and similar roles within viral infection.   
zNP and zVP35 both play an important role in the replication of EBOV, with 
both being involved in the formation of the replication complex and inclusion bodies 
synthesis [Mahanty, 2004] [Hoenen, T.,2012]. Inclusion bodies are the sites of viral RNA 
synthesis within Ebolavirus, as well as being the site where nucleocapsids of 
differing maturation are found [Dolnik,O., 2015]. The induction of autophagy via these 
EBOV proteins suggests that autophagy may play a role in the replication of 
EBOV, such as aiding in the formation of the inclusion bodies, or bringing cellular 
components to the inclusion bodies. However, the other protein that induced 
autophagy, zVP40, does not play a role in replication, but is required for transport 
of the inclusion bodies to the plasma membrane, as well as being essential in viral 
egress [Noda, T., 2006] [Han, Z., 2017]. This suggests that autophagy could be also 
play a role in viral transport throughout the cell, and then viral egress.  
4.4 Co-localisation of LC3 puncta with EBOV proteins 
 
To determine whether the EBOV proteins were interacting with the 
autophagosomes, or were just inducing the autophagy pathway, co-localisation of 
LC3 puncta and EBOV proteins was determined.  As seen in Figure 10, the EBOV 
proteins that had been seen to activate autophagy; zNP, zVP35 and zVP40 all co-
ORFDOLVHGZLWKWKH/&SXQFWD¶V, although to varying degrees. 
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 Co-localisation of the EBOV protein with LC3 puncta suggests that the 
proteins themselves are interacting with the autophagosome in some way. 
Interaction with autophagosomes could suggest that EBOV proteins are being 
selectively targeted via the autophagy pathway for degradation via the 
autolysosome. During HIV-1 infection, the HIV-1 protein Tat, which is essential for 
viral transcription and virion production, is selectively degraded via the autophagy 
pathway [Sagnier,S., 2015]. This degradation could be happening during EBOV 
infection. However, it could also suggest that the EBOV proteins are subverting the 
autophagy pathway, and are using the autophagosomes to aid in viral infection, 
such as during Polio viral infection, during which it appears that the autophagy 
pathway acts in a pro-viral way, facilitating viral replication within the cell 
[Jackson,W.,T., 2005].   .   
4.5 Co-localisation of LC3 puncta with Lamp1 
Increased levels of LC3 puncta can be associated with either an increase in 
autophagosome synthesis or reduced autophagosomal turnover [Barth,S., 2010]. 
Reduced autophagosomal turnover could occur due to a variety of reasons such as 
reduced fusion with lysosomes or endosomes, or delayed trafficking to the 
lysosomes [Barth,S., 2010].  
To determine whether the EBOV proteins were reducing the autophagosomal 
turnover, and therefore the maturation of the autophagy pathway, the co-
localisation of Lamp1 with LC3 puncta was investigated. Lamp1 is a lysosomal 
protein that is trafficked to autophagosomes during maturation [Jackson,W.,T., 2005], 
and so can be used to determine if there is reduced autophagosomal turnover. As 
can be seen from Figure 11, Lamp1 puncta that co-localise with LC3 puncta can be 
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seen for zNP, zVP35 and zVP40. This suggests that fusion of the autophagosomes 
and lysosomes is occurring.  
Previously, it has been seen that Lamp1 is recruited into Marburg NP 
inclusions, and that co-expression of NP and VP40 causes co-localisation of 
Lamp1 with VP40 in VP40 clusters, and NP inclusions containing VP40 [Dolnik, 
O.,2015]. However, Lamp1 is an endolysosomal marker, and is seen in other 
pathways as well as autophagy. The co-localisation of LC3 with Lamp1 within 
these clusters and inclusions was not visualised during the study which could 
mean that the interaction seen with Marburg proteins was not due to maturation of 
autophagosomes.  
However, the co-localisation of Lamp1 and LC3 has been seen in viruses that 
do interact with the autophagy pathway during viral infection. During poliovirus 
infection, LC3 containing double-membrane vesicles have been identified. Within 
these vesicles, LC3 and Lamp1 are seen to co-localise [Jackson,W.,T., 2005].  During 
poliovirus infection, it appears that the autophagy pathway and the production of 
these vesicles act in a pro-viral way, facilitating viral replication within the cell 
[Jackson,W.,T., 2005].  Therefore, the co-localisation of Lamp1 with LC3 and the 
EBOV proteins could suggest that the virus is subverting the pathway to aid in viral 
replication, as two of the proteins that activate the pathway are involved in the 
formation of the replication complex for EBOV.  
Alternatively, the co-localisation of Lamp1 and LC3 could suggest that the 
autophagy pathway is reaching maturation and is causing the degradation of 
EBOV proteins that have been taken up into the autophagosomes. This would 
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suggest that the pathway is acting in an anti-viral way, removing vital viral proteins 
from the cell, hindering the replication of the virus.   
4.6 EBOV proteins prevent autophagic flux 
To determine if the degradation of the proteins present within the 
autophagolysosmes occurs, levels of p62 were investigated. p62 interacts with LC3 
and is then degraded by autophagy [Barth,S., 2010]. Due to this, levels of p62 can be 
used to determine autophagic flux, with p62 levels correlating inversely with 
autophagy. As can be seen in Figure 12, all three EBOV proteins, zNP, zVP35 and 
zVP40 cause an increase in p62 levels compared to the negative control. This 
could be due to the proteins preventing autophagic flux and the degradation of 
autophagolysosmes, or it could be due to the proteins causing an overexpression 
of p62. To determine which scenario is occurring, the autophagic flux inhibitor 
chloroquine was used. If the EBOV proteins were causing an overexpression of 
p62, when chloroquine is added, levels of p62 will increase as degradation of the 
overexpressed p62 will be prevented. As can be seen from Figure 13, levels of p62 
in the EBOV protein samples are relatively similar in the absence and presence of 
chloroquine, suggesting that the proteins are not causing an overexpression of 
p62, but are preventing autophagic flux.  
Other viruses are known to inhibit autophagic flux to aid in viral replication. 
During the reactivation of Epstein-Barr virus from latency, the autophagy pathway 
is activated but autophagic flux is blocked [Granato,M., 2014]. This block of 
autophagic flux can be attributed to the down regulation of the autophagosomal 
maturation protein, Rab7 [Wang,M., 2015]. Blocking autophagic flux allows the 
Epstein-Barr virus to use the autophagic vesicles for intracellular transportation and 
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viral production [Granato,M., 2014]. Preventing autophagic flux may also allow 
Epstein-Barr virus to avoid degradation by the autolysosome [Wang,M., 2015]. The 
induction and then subversion of the autophagy pathway seen by EBOV could 
indicate that the autophagy pathway is playing an important role in EBOV 
replication.   
4.7 Decrease in replication of EBOV in HeLa-Hex cells compared to 
HeLa cells 
To determine if the autophagy pathway plays a role in the replication of EBOV, 
a trVLP system, as seen in Figure 19, was used in HeLa and HeLa-Hex cells.  
 
 
The replication and transcription of EBOV can then be tested for by looking at 
the reporter activity of luciferase. Hex cells are HeLa cells that have all eight 
variants of the ATG8 (LC3) protein knocked out. Due to this, HeLa-Hex cells can 
be used to compare replication rates of EBOV between autophagy deficient and 
normal cells. As can be seen from Figure 15, the luciferase reporter activity is 
A schematic diagram showing 
the transfection of plasmids 
and minigenome into the cell. 
The minigenome is then 
replicated and transcribed 
before assembly and budding 
occurs [Watt,A., 2014].  
 
Figure 19: Schematic 
diagram to show trVLP 
system in p0 cells 
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greatly reduced in p0 HeLa-Hex cells compared to HeLa cells. This suggests that 
when the autophagy pathway is removed from cells, EBOV is unable to replicate 
as effectively.  
NP and VP35 are both vital proteins required in the replication of EBOV.  Along 
with VP30 and L, they form the replication complex required to generate mRNA 
transcripts and full-length positive sense RNA antigenomes, which act as 
templates for genome synthesis [Mahanty, 2004]. As well as forming the actual 
replication complex, NP and VP35 are both involved in the formation of inclusion 
bodies which act as the site of viral replication [Hoenen,T.,2012]. The activation of 
autophagy by these two proteins, and the reduction of EBOV replication seen in 
HeLa-Hex cells suggests that the interaction of these two proteins with the 
autophagy pathway could be linked to their roles in the replication cycle of EBOV. 
These proteins could be using the autophagic vesicles for viral production as seen 
in Epstein-Barr viral infection [Granato,M., 2014]. 
4.8 Increase in budding of EBOV in HeLa-Hex cells compared to HeLa 
cells 
To determine the effect the autophagy pathway has on the budding of 
EBOV, the trVLP system was used. After replication and transcription has taken 
place in the p0 cells, V/3¶VEXGIrom the cells and are released into the 
supernatant. This supernatant can then be clarified and placed onto new cells, p1, 
ZKHUHHQWU\DQGUHSOLFDWLRQRIWKH9/3¶VLQWKHQHZFHOOVFDQWDNHSODFHDVVHHQLQ
Figure 20.  
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A schematic diagram showing the transfection of plasmids and 
minigenome into p0 cells. The minigenome is then replicated and 
transcribed before assembly and budding occurs. The supernatant is 
then passaged onto new p1 cells [Watt,A., 2014] 

















To determine the effect autophagy has on budding, the trVLP system can be 
transfected into HeLa and HeLa-Hex p0 cells, then passaged onto HeLa p1 cells, 
meaning autophagy only plays a role in the replication, transcription and budding 
that occurs in p0 cells. As can be seen from Figure 16, luciferase reporter activity is 
still slightly higher in the p1 cells with HeLa p0 supernatant, compared to the p1 
cells with HeLa-Hex supernatant. However as seen from Figure 18, the percentage 
decrease from the luciferase reporter activity from p0 to p1 HeLa cells is greater 
than the percentage decrease seen in HeLa-Hex p0 cells, although this difference 
is not statistically significant. However, it could still suggest that there was less 
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budding from the HeLa cells, causing a decrease in the luciferase reporter activity 
seen in the p1 cells. This suggests that autophagy is preventing the budding of 
EBOV in some way. 
VP40, one of the proteins seen to cause induction of autophagy is essential for 
the budding of EBOV. VP40 is required for the transport of the nucleocapsids to 
the plasma membrane [Noda,T., 2006]. VP40 then recruits vital proteins for viral 
egress, allowing the release of the newly synthesised viral particles [Han,Z., 2017].  
The apparent increase in budding from HeLa-Hex cells compared to HeLa cells 
suggests that the interaction of VP40 with the autophagy pathway could be acting 
in an anti-viral way.  
However, the results seen in Table 5 are affected by transcription, replication 
and budding within p0. Figure 15 clearly shows that there is a difference in the 
transcription and replication between HeLa and HeLa-Hex cells. It is logical to 
assume that increased replication would also lead to increased levels of budded 
virions but this budding could be affected by other scenarios, such as maximal 
budding limits for HeLa and HeLa-Hex cells. If the maximal budding limit for the 
+H/D¶VZDVUHDFKHGGXULQJWKHH[SHULPHQWV but not for the HeLa-Hex cells, this 
could lead to inaccurate representations of the amount of budding that occurs. This 
would mean that the greater decrease in luciferase reporter activity seen in the 
+H/D¶Vmay QRWDFFXUDWHO\UHSUHVHQWWKHWUXHEXGGLQJDELOLW\RIWKH+H/D¶VThis 
could affect the luciferase reporter activity seen in Table 5, and so affect the 
conclusions on the effect autophagy has on budding.  
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4.9 Conclusion 
In this study it has been shown that certain EBOV proteins, zNP, zVP35 and 
zVP40 are able to induce the autophagy pathway and co-localise with the 
autophagosomes produced. These autophagosomes then appear to undergo 
fusion with the lysosomes, but do not undergo full maturation, with autophagic flux 
being prevented. The overall autophagy pathway appears to play a role in the viral 
replication of EBOV. Ebolavirus could induce the autophagy pathway to aid in the 
formation of inclusion bodies which are essential for viral replication. However, 
robust autophagy could then hinder viral budding, perhaps by preventing transport 
of key viral components to the plasma membrane. 
Future experiments could aid in confirming and developing the knowledge of 
the interaction of EBOV with the autophagy pathway. Experiments to confirm the 
role of autophagy in the budding of EBOV need to be carried out, to eliminate the 
possibility that other factors played a role in the decrease seen in luciferase 
reporter activity seen in Figure 17. To determine that there is no budding limit, and 
that increases in budding correlates with increases in replication, a trVLP 
experiment which alters the levels of plasmid DNA transfected, but not the ratio of 
plasmids could be run. The luciferase reporter activity for p0 and p1 could then be 
analysed. If there is no budding limit, and budding and replication do correlate, 
then the luciferase reporter activity of p0 and p1 should both decrease as plasmid 
concentration decreases. This would then allow the exact determination of the role 
autophagy plays in the budding of EBOV.  
To try and develop a greater understanding of the interaction of the EBOV 
proteins with LC3, LIR mutants based on the predicted LIR domains listed in this 
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study could be created. Experiments looking into the effect these mutants have on 
the induction of autophagy could help to understand the exact interaction occurring 
between EBOV proteins and LC3. RESTV LIR domains were determined during 
this study, but the interaction of RESTV proteins with the autophagy pathway were 
not studied due to time constraints. These experiments could provide a greater 
understanding into the different pathogenicity seen between RESTV and the other 
Ebolavirus species.  
The results determined via this study provide a greater understanding into the 
interaction that EBOV proteins have with the cellular autophagy pathway during 
infection. Understanding the effect EBOV has on cellular processes leads to a 
greater understanding of how the virus is able to survive and reproduce within the 
host which can lead to the development of novel therapeutic targets. Studies have 
shown that inhibiting autophagy during viral infections can lead to a decrease in 
viral titre and viral replication. An autophagy inhibitor, spautin-1, was able to greatly 
affect the production of infectious particles of dengue virus [Mateo,R., 2013]. Spautin-
1 is a highly selective early stage autophagy inhibitor, with it being able to cause 
the degradation of the Beclin-Vps34-Atg14 complex, as well as decreasing 
intracellular concentrations of phosphatidylinositol 3-phosphate, a lipid required for 
the initiation of autophagosome formation [Mateo,R., 2013].  An autophagy inhibitor 
like this could be tested against EBOV to see the effect it has on viral replication. 
Currently derivates of spautin-1 are being developed as therapeutic drugs to target 
autophagy [Kotz,J., 2011], which could eventually act as a therapeutic drug against 
viruses that subvert the autophagy pathway for viral replication.  
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6 Supplementary data 
6.1 EBOV LIR domains 
 
Protein Start End LIR sequence PSSM Score Pattern 
zL 87 92 NGFCPV 4 WxxL 
zL 150 155 FFWYDL 10 WxxL 
zL 188 193 YVFWKI 0 WxxL 
zL 268 273 PNFKIV 7 WxxL 
zL 290 295 DGYKII 13 WxxL 
zL 424 429 GSWYSV 13 WxxL 
zL 446 451 NQFPPL 3 WxxL 
zL 459 464 WEFYHL 5 WxxL 
zL 492 497 TCWDAV 12 WxxL 
zL 561 566 RTFGKL 7 WxxL 
zL 671 676 QCYMHV 3 WxxL 
zL 714 719 KLWTSI 13 WxxL 
zL 828 833 AIFDDL 7 WxxL 
zL 864 869 HTFFSV 4 WxxL 
zL 872 877 LQYHHL 5 WxxL 
zL 894 899 LDFGTI 10 WxxL 
zL 920 925 CFYRNL -2 WxxL 
zL 947 952 DLFLPL 9 WxxL 
zL 1084 1089 LWFSYL 1 WxxL 
zL 1116 1121 YSWAHI 12 WxxL 
zL 1162 1167 KPFVSV 7 WxxL 
zL 1314 1319 IIFQNV 1 WxxL 
zL 1457 1462 LTYPKI 6 WxxL 
zL 1592 1597 FLYQIV 8 WxxL 
zL 1763 1768 LPFFTL 4 WxxL 
zL 1804 1809 CRFTGI 2 WxxL 
zL 1853 1858 LFFNTL 2 WxxL 
zL 1938 1943 KLYEAV 7 WxxL 
zL 1999 2004 EWYLCL 5 WxxL 
zL 2054 2059 LSYIRL 9 WxxL 
zL 2070 2075 HRYNLV 2 WxxL 
zL 2112 2117 QTYHFI 8 WxxL 
zL 2132 2137 LKFFLI 4 WxxL 
zL 2149 2154 AEFKKL 9 WxxL 
zL 2162 2167 NRFYHI 3 WxxL 
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Protein Start End LIR sequence PSSM Score Pattern 
zNP 19 24 MDYHKI 10 WxxL 
zNP 151 156 LSFASL 6 WxxL 
zNP 189 194 TAWQSV 12 WxxL 
zNP 210 215 IKFLLI 6 WxxL 
zNP 239 244 ARFSGL 3 WxxL 
zNP 294 299 APFARL 3 WxxL 
zNP 311 316 GLFPQL 1 WxxL 
zNP 338 343 EQYQQL 9 WxxL 
zNP 650 655 EMYRHI 9 WxxL 
zNP 660 665 GPFDAV 7 WxxL 
zNP 710 715 NRFVTL 8 WxxL 
zNP 719 724 QFYWPV 0 WxxL 
zNP 729 734 NKFMAI 5 WxxL 
 
Protein Start End LIR sequence PSSM Score Pattern 
zGP 18 23 SFFLWV 2 WxxL 
zGP 160 165 FLYDRL 8 WxxL 
zGP 181 186 VAFLIL 6 WxxL 
zGP 239 244 LTYVQL 10 WxxL 
zGP 306 311 LSFTVV 9 xLIR 
zGP 580 585 RTFSIL 10 WxxL 
 
Protein Start End LIR sequence PSSM Score Pattern 
zVP24 6 11 GRYNLI 5 WxxL 
zVP24 40 45 VYWAGI 6 WxxL 
zVP24 74 79 NLFPHL 1 WxxL 
zVP24 170 175 VNYNGL 3 WxxL 
zVP24 217 222 AKFSLL 6 WxxL 
 
Protein Start End LIR sequence PSSM Score Pattern 
zVP30 209 214 EVYQRL 7 WxxL 
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Protein Start End LIR sequence PSSM Score Pattern 
zVP35 42 47 DIFCDI 5 WxxL 
zVP35 81 86 HSFEEV 9 WxxL 
zVP35 140 145 AKYDLL 10 WxxL 
zVP35 198 203 EAFNNL 3 WxxL 
zVP35 227 232 IMYDHL 10 WxxL 
zVP35 237 242 TAFHQL 2 WxxL 
zVP35 322 327 RGWVCV 16 WxxL 
 
Protein Start End LIR sequence PSSM Score Pattern 
zVP40 93 98 PIWLPL 13 WxxL 
zVP40 245 250 QDFKIV 11 WxxL 
zVP40 290 295 PKYIGL 7 WxxL 
 
6.2 RESTV LIR domains 
 
Protein Start End LIR Sequence  PSSM Score  Pattern 
rL 53 58 LKFDTI 9 WxxL 
rL 150 155 FFWHDL 10 WxxL 
rL 177 182 DEFIDI 14 xLIR 
rL 188 193 YIFWKI 0 WxxL 
rL 290 295 EGYKII 11 WxxL 
rL 349 354 RDFHKI 12 WxxL 
rL 363 368 QQFCEL 4 WxxL 
rL 424 429 GTWYSV 13 WxxL 
rL 446 451 NHFPSL 2 WxxL 
rL 459 464 WEFYHL 5 WxxL 
rL 492 497 TCWDAV 12 WxxL 
rL 561 566 RTFGKL 7 WxxL 
rL 671 676 QCYMHV 3 WxxL 
rL 714 719 KLWTSI 13 WxxL 
rL 828 833 AIFDDL 7 WxxL 
rL 864 869 HTYFAV 5 WxxL 
rL 872 877 LQYHHL 5 WxxL 
rL 894 899 LDYGTI 11 WxxL 
rL 947 952 DLFCPL 5 WxxL 
rL 1084 1089 LWFSYL 1 WxxL 
rL 1116 1121 YTWSHI 13 WxxL 
rL 1160 1165 NAYVSV 7 WxxL 
rL 1312 1317 IIFQNV 1 WxxL 
rL 1412 1417 LRFPHL 2 WxxL 
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rL 1455 1460 LTYPQI 5 WxxL 
rL 1464 1469 YSFGAV 3 WxxL 
rL 1679 1684 EKYYNV 4 WxxL 
rL 1761 1766 LPFFKL 3 WxxL 
rL 1802 1807 CRFTGI 2 WxxL 
rL 1936 1941 QLYRAV 2 WxxL 
rL 1951 1956 PQYLKV 8 WxxL 
rL 1997 2002 EWYLCL 5 WxxL 
rL 2052 2057 CEYIGL 7 WxxL 
rL 2068 2073 HRYNLV 2 WxxL 
rL 2110 2115 QTYHFI 8 WxxL 
rL 2130 2135 LKFSLI 5 WxxL 
rL 2144 2149 SWYTEL 8 WxxL 
 
Protein Start End LIR Sequence  PSSM Score  Pattern 
rNP 19 24 LDYHKI 11 WxxL 
rNP 151 156 LSFASL 6 WxxL 
rNP 189 194 TAWQSV 12 WxxL 
rNP 210 215 IKYLLI 7 WxxL 
rNP 239 244 ARFSGL 3 WxxL 
rNP 294 299 APFARL 3 WxxL 
rNP 311 316 GLYPQL 2 WxxL 
rNP 338 343 EQYQQL 9 WxxL 
rNP 599 604 PDYTAV 14 xLIR 
rNP 650 655 ETYHHL 9 WxxL 
rNP 660 665 GPFEAI 8 WxxL 
rNP 710 715 NRYIYI 8 WxxL 
rNP 719 724 QFFWPV -1 WxxL 
rNP 729 734 DKFLAI 11 WxxL 
 
Protein Start End LIR Sequence  PSSM Score  Pattern 
rGP 3 8 SGYQLL 12 xLIR 
rGP 21 26 LVWVII 14 xLIR 
rGP 161 166 FLYDRL 8 WxxL 
rGP 182 187 VAFLIL 6 WxxL 
rGP 212 217 SYYMTL 7 WxxL 
rGP 240 245 HTYVQL 9 WxxL 
rGP 307 312 LHFQIL 7 WxxL 
rGP 517 522 YYWTAV 10 WxxL 
rGP 581 586 RTYSLL 10 WxxL 
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Protein Start End LIR Sequence  PSSM Score  Pattern 
rVP24 6 11 GRYNLV 4 WxxL 
rVP24 21 26 VIFSDL 2 WxxL 
rVP24 40 45 VYWAGI 6 WxxL 
rVP24 74 79 NLFPHL 1 WxxL 
rVP24 170 175 VNYNGL 3 WxxL 
rVP24 217 222 VKFSLL 4 WxxL 
rVP24 228 233 KPFTRV 5 WxxL 
rVP24 243 248 MEFNSL 6 WxxL 
 
Protein Start End LIR Sequence  PSSM Score  Pattern 
rVP30 209 214 EVYQRL 7 WxxL 
rVP30 240 245 SAFLNI 6 WxxL 
 
Protein Start End LIR Sequence  PSSM Score  Pattern 
rVP35 31 36 DIFIDI 9 WxxL 
rVP35 66 71 VNYVPL 9 WxxL 
rVP35 129 134 AKYDLL 10 WxxL 
rVP35 187 192 EAYKNL 5 WxxL 
rVP35 216 221 IMYDHL 10 WxxL 
rVP35 226 231 TAFHQL 2 WxxL 
rVP35 274 279 PIFQDV 5 WxxL 
rVP35 311 316 RGWVCL 17 WxxL 
 
Protein Start End LIR Sequence  PSSM Score  Pattern 
rVP40 93 98 PIWLPL 13 WxxL 
rVP40 123 128 THFGKI 2 WxxL 
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zVP24 zGP PCAGGs 
MEF cells were transfected with individual EBOV proteins, as indicated besides the 
images, and GFP-LC3. Activation of autophagy is seen by the formation of LC3 
puncta. LC3 puncta can be seen as bright green dots, or aggregations. All slides were 
fixed at 24hrs post transfection and analysed by fluorescence microscopy. Nuclei are 
stained blue by DAPI. 
 
